Related Experiment Video
Updated: Oct 7, 2025

A 1.5 Hour Procedure for Identification of Enterococcus Species Directly from Blood Cultures
Published on: February 10, 2011
Ampicillin Plus Ceftriaxone Combined Therapy for Enterococcus faecalis Infective Endocarditis in OPAT
Laura Herrera-Hidalgo1,2, Jose Manuel Lomas-Cabezas2, Luis Eduardo López-Cortés3
1Unidad de Farmacia, Hospital Universitario Virgen del Rocío/CSIC/Instituto de Biomedicina de Sevilla (IBiS), 41013 Seville, Spain.
Insights
Ampicillin plus ceftriaxone (AC) regimens for Enterococcus faecalis infective endocarditis (IE) are challenging in outpatient parenteral antibiotic treatment (OPAT). The ACjoined regimen shows promise as an effective alternative for OPAT, warranting further investigation.
Area of Science:
- Infectious Diseases
- Cardiology
- Pharmacology
Background:
- Ampicillin plus ceftriaxone (AC) is a standard inpatient treatment for Enterococcus faecalis infective endocarditis (IE).
- Standard AC regimens require frequent dosing, posing challenges for outpatient parenteral antibiotic treatment (OPAT) programs.
- Alternative AC dosing strategies, including AC24 (once-daily high-dose ceftriaxone) and ACjoined (co-diluted, 4-hourly bolus), have been proposed for OPAT.
Purpose of the Study:
- To evaluate the clinical effectiveness and safety of three different ampicillin plus ceftriaxone (AC) regimens for treating Enterococcus faecalis infective endocarditis (IE).
- To compare the outcomes of AC12 (standard inpatient), AC24, and ACjoined regimens in patients with E. faecalis IE.
Main Methods:
- Retrospective analysis of prospectively collected data from 59 patients with E. faecalis IE.
- Patients were treated with one of three AC regimens: AC12 (n=32), AC24 (n=17), or ACjoined (n=10).
- Outcomes assessed included cure rates, relapses, and unplanned readmissions.
Main Results:
- Overall cure rates were high across all groups: AC12 (93.3%), AC24 (94.1%), and ACjoined (80.0%).
- The AC24 regimen showed a significantly higher relapse rate (29.4%) compared to ACjoined (10.0%).
- Unplanned readmission rates varied: AC12 (25.0%), AC24 (35.3%), and ACjoined (20.0%).
Conclusions:
- Optimizing the delivery of ampicillin plus ceftriaxone combinations is crucial for successful E. faecalis IE treatment in OPAT settings.
- The AC24 regimen demonstrated an unexpected high failure rate.
- The ACjoined regimen may represent an effective alternative for E. faecalis IE in OPAT, requiring further validation in prospective studies.
Abstract:
Ampicillin plus ceftriaxone (AC) is a well-recognized inpatient regimen for Enterococcus faecalis infective endocarditis (IE). In this regimen, ceftriaxone is usually administered 2 g every 2 h (AC12). The administration of AC in outpatient parenteral antibiotic treatment (OPAT) programs is challenging because multiple daily doses are required. AC regimens useful for OPAT programs include once-daily high-dose administration of ceftriaxone (AC24) or AC co-diluted and jointly administered in bolus every 4 h (ACjoined). In this retrospective analysis of prospectively collected cases, we aimed to assess the clinical effectivity and safety of three AC regimens for the treatment of E. faecalis IE. Fifty-nine patients were treated with AC combinations (AC12 n = 32, AC24 n = 17, and ACjoined n = 10). Six relapses occurred in the whole cohort: five (29.4%) treated with AC24 regimen and one (10.0%) with ACjoined. Patients were cured in 30 (93.3%), 16 (94.1%), and eight (80.0%) cases in the AC12, AC24 and ACjoined groups, respectively. Unplanned readmission occurred in eight (25.0%), six (35.3%), and two (20.0%) patients in the AC12, AC24 and ACjoined groups, respectively. The outcome of patients with E. faecalis IE treated with AC in OPAT programs relies on an optimization of the delivery of the combination. AC24 exhibit an unexpected rate of failures, however, ACjoined might be an effective alternative which clinical results should corroborate in further studies.
More Related Videos
12:03Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
Published on: April 18, 2019
11:15Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
Published on: July 24, 2021
Related Concept Videos
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Endocarditis I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Acute Pyelonephritis II: Diagnostic Studies and Management
Combined Effects of Drugs: Synergism
Such synergistic combinations...